H-ASP-ASP-ASP-ASP-OH(145224-95-9)
- Name: H-ASP-ASP-ASP-ASP-OH
- Synonyms:L-Asparticacid, N-[N-(N-L-a-aspartyl-L-a-aspartyl)-L-a-aspartyl]-; 10: PN: WO03100015SEQID: 10 claimed sequence; 114: PN: WO2008134544 SEQID: 119 unclaimed protein;121: PN: WO2008113030 SEQID: 124 unclaimed sequence; 15: PN: GB2433505 PAGE: 42unclaimed sequence; 33: PN: DE102007002386 PAGE: 16/16 claimed protein; 36: PN:WO03099853 SEQID: 36 claimed sequence; 37: PN: WO2008083678 PAGE: 33 claimedprotein; 3: PN: WO0126682 SEQID: 1 claimed sequence; 6: PN: WO2008035093 PAGE:6 unclaimed sequence; Tetra-aspartic acid
- Molecular Formula:C16H22 N4 O13
- Molecular Weight:478.36
- CAS Registry Number:145224-95-9
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 141197-27-5/(-)-Ipratropine
- 145204-53-1/CARCINOEMBRYONIC ANTIGEN (101-115)
- 145206-43-5/Pyrazine, 2,5-dihydro-3,6-dimethoxy-2-propyl-, (R)- (9CI)
- 145208-40-8/2-Butenamide, 2-cyano-3-hydroxy-N-methyl- (9CI)
- 145208-86-2/Pyrimidine, 2-(4-methyl-1-piperazinyl)- (9CI)
- 145208-85-1/Piperazine, 1-methyl-4-(2-pyridinyl)- (9CI)
- 145211-77-4/(2S,4S,5R,6R)-5-acetamido-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2R,3S,4S,5S,6R)-2-[(2R,3R,4S,5S,6S)-2-[[(2S,3S,4S,5S,6R)-3-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4S,5S,6R)-4-[(2S,4S,5R,6R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-6-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2R,3S,4R,5R)-5-acetamido-4,6-dihydroxy-2-(hydroxym
- 145214-57-9/(R)-(+)-2,2'-Bis(di-2-furanylphosphino)-6,6'-dimethoxy-1,1'-biphenyl,min.97%
- 145214-59-1/(S)-(-)-2,2'-Bis(di-2-furanylphosphino)-6,6'-dimethoxy-1,1'-biphenyl,min.97%
- 145218-92-4/Benzoic acid, 2-amino-6-methyl-, 2-propenyl ester (9CI)
- 141208-49-3/Cyclobutanecarboxylic acid, 2,3-bis(hydroxymethyl)-, [1S-(1alpha,2alpha,3beta)]- (9CI)
- 145218-96-8/Benzoic acid, 2-amino-5-methyl-, 2-propenyl ester (9CI)
- 141210-78-8/Methanamine, 1-(2-ethoxy-3H-indol-3-ylidene)-N,N-dimethyl-, (E)- (9CI)
- 141223-69-0/ANTHRANILYL-HIV PROTEASE SUBSTRATE IV
- 145224-90-4/5-HYDROXY-L-TRYPTOPHAN HYDRATE
- 145243-97-6/SECOBARBITAL-D5
- 141327-44-8/2-Acetyl-butanoic-d5 Acid Ethyl Ester
- 141327-54-0/METHYL 3-(4-FLUOROPHENYL)-5-METHYLINDOLE-2-CARBOXYLATE
- 141333-27-9/ETHYL 4-(4-FORMYL-2-METHOXYPHENOXY)BUTANOATE
- 145224-95-9/H-ASP-ASP-ASP-ASP-OH
- 145224-96-0/hexaaspartic acid
- 141232-84-0/2-Cyclobutene-1-carboxylic acid, 1-formyl-, methyl ester (9CI)
- 145224-98-2/DNP-PRO-LEU-GLY-CYS(ME)-HIS-ALA-D-ARG-NH2
- 145225-01-0/ALPHA-HYDROXYTRIAZOLAM-D4
- 145225-03-2/Oxymorphone-d3
- 145225-04-3/TRIAZOLAM-D4
- 141238-13-3/Benzoic acid, 3-amino-4-(methylthio)-, methyl ester (9CI)
- 141238-15-5/Benzoic acid, 3-amino-4-ethoxy-, ethyl ester (9CI)
- 145232-34-4/3-CYCLOHEXYL-L-ALANINE AMIDE
- 141250-32-0/2(3H)-Benzofuranone, 3-(hydroxymethylene)-, (E)- (9CI)